1,5-benzodiazepine compounds, their production and use
申请人:——
公开号:US20030149027A1
公开(公告)日:2003-08-07
A compound represented by the formula (I)
1
[wherein ring B represents a cyclic hydrocarbon group which may have substituent(s); Z represents hydrogen atom or a cyclic group which may have substituent(s); R
1
represents hydrogen atom, a hydrocarbon group which may have substituent(s), a heterocyclic group which may have substituent(s) or an acyl group; R
2
represents amino group which may have substituent(s); D represents a bond or a divalent group; E represents a bond, —CO—, —CON(R
a
)—, —COO—, —N(R
a
)CON(R
b
)—, —N(R
a
)COO—, —N(R
a
)SO
2
—, —N(R
a
)—, —O—, —S—, —SO— or —SO
2
— (R
a
and R
b
each independently represents hydrogen atom or a hydrocarbon group which may have substituent(s)); G represents a bond or a divalent group; L represents a bond or a divalent group; A represents hydrogen atom or a substituent; X and Y each represents hydrogen atom or an independent substituent; and . . . represents that R
2
and an atom on ring B may form a ring] or a salt thereof, and a process for producing the same.
[EN] HETEROARYLS AND THEIR USE AS PI3K INHIBITORS<br/>[FR] HÉTÉROARYLES ET APPLICATIONS ASSOCIÉES
申请人:MILLENNIUM PHARM INC
公开号:WO2010090716A1
公开(公告)日:2010-08-12
This invention provides compounds of formula (IA) or (IB): wherein R1, R2, G1 and HY are as described in the specification. The compounds are inhibitors of PI3K and/or mTor and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
The present invention relates to a compound represented by the formula:
wherein W is C(R
1
) or N, each A is an optionally substituted aryl group or a heteroaryl group, X
1
is —NR
3
—Y
1
—, —O—, —S—, —SO—, —SO
2
— or —CHR
3
— wherein R
3
is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group, or R
3
is optionally bonded to A to form an optionally substituted ring structure, R
1
is a hydrogen atom or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom, R
2
is a hydrogen atom or optionally substituted group bonded via a carbon atom or a sulfur atom, or R
1
and R
2
, or R
2
and R
3
are optionally bonded to form an optionally substituted ring structure, or a salt thereof, and a tyrosine kinase inhibitor or an agent for the prophylaxis or treatment of cancer, which contains this compound or a prodrug thereof.
The compound of the present invention is represented by the following formula 1:
wherein R
1
, R
2
, R
4
, R
5
, m0 to m2, and n0 to n2 are as defined in the description. Radiation sensitive compositions containing the compound of the formula 1 as a main component of the solid component are excellent in sensitivity, resolution, heat resistance, etching resistance, and solubility in solvent.